4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001415889-23-009369
CEO sold 6,486 shares at $9.50 ($61,638)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| O'Neill Gilmore Neil CEO | 2023-06-05 | Sale 10b5-1 | −6,486 | $9.50 | $61,638 | 130,169 | D |
| Open-market sales · 6,486 sh · avg $9.50 · $61,638 | |||||||
Loading xslF345X04/form4-06072023_040605.xml…